|
Market Closed -
NYSE
16:00:02 2026-10-13 EDT
|
5-day change | 1st Jan Change | ||
| 87.55 USD | -0.22% |
|
+1.30% | +10.32% |
| 10-13 | Health Care Down After Mixed Earnings - Health Care Roundup | DJ |
| 10-13 | CVS to Pay $315 Million to Settle Opioid-Prescription Allegations, DOJ Says | MT |
| Market Cap | 112B 100B 93.23B 84.53B 159B 10,629B 160B 1,117B 437B 5,528B 421B 411B 17,738B | P/E 2026 * |
12.7x | P/E 2027 * | 12.1x |
|---|---|---|---|---|---|
| Enterprise Value | 164B 146B 136B 124B 233B 15,554B 235B 1,634B 640B 8,089B 615B 602B 25,958B | EV / Sales 2026 * |
0.39x | EV / Sales 2027 * | 0.37x |
| Free-Float |
71.17% | Yield 2026 * |
3.04% | Yield 2027 * | 3.13% |
| Markets | Quality | ||
|---|---|---|---|
NYSE
| CVS | Delayed | |
CBOE
| CVS | Real-time | |
|
Tradegate
| CVS | Real-time | |
|
Xetra
| CVS | Delayed | |
|
Boerse Muenchen
| CVS | Real-time | |
|
London S.E.
| 0HRS | Delayed | |
|
Mexican S.E.
| CVS * | End-of-day quote | |
|
Deutsche Boerse AG
| CVS | Delayed | |
|
Santiago S.E.
| CVSCL | End-of-day quote | |
|
Swiss Exchange
| CVS | Delayed | |
|
CBOE
| Real-time | ||
|
CBOE
| 0HRS | Real-time | |
|
Santiago S.E.
| CVS | End-of-day quote | |
|
Borsa Italiana
| 1CVS | End-of-day quote | |
|
Lima
| CVSUS | End-of-day quote | |
|
Wiener Boerse
| CVS | End-of-day quote | |
|
Börse Stuttgart
| CVS | Delayed | |
|
Swiss Exchange
| CVS | Delayed |
Last Transcript: CVS Health Corporation
| 1 day | -0.22% | ||
| 1 week | +1.30% | ||
| Current month | +2.17% | ||
| 1 month | -7.51% | ||
| 3 months | -17.33% | ||
| 6 months | +12.11% | ||
| Current year | +10.32% |
| 1 week | 85.8 |  | 89.89 |
| 1 month | 84.23 | | 95.75 |
| Current year | 69.51 | | 110.68 |
| 1 year | 69.51 | | 110.68 |
| 3 years | 43.56 | | 110.68 |
| 5 years | 43.56 | | 111.25 |
| 10 years | 43.56 | | 111.25 |
| Manager | Title | Age | Since |
|---|---|---|---|
J. Joyner
CEO | Chief Executive Officer | 62 | 2024-10-16 |
Ali Keshavarz
PSD | President | - | - |
Brian Newman
DFI | Director of Finance/CFO | 57 | 2025-05-11 |
| Director | Title | Age | Since |
|---|---|---|---|
C. Brown
BRD | Director/Board Member | 74 | 2007-02-28 |
Anne Finucane
BRD | Director/Board Member | 73 | 2011-01-19 |
| Director/Board Member | 71 | 2015-03-04 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 5/31/26 | Tax | Chief Financial Officer | -2,478 | 0.0002% | ||
| 5/31/26 | Tax | Chief Technology Officer | -7,618 | 0.0006% | ||
| 5/21/26 | Glenview Capital Management LLC
| Sell | Company | -748,462 | 0.0584% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.22% | +1.30% | +11.61% | +22.38% | 112B | |
| +0.47% | +6.61% | +12.19% | +94.07% | 99.29B | |
| -0.53% | -1.25% | +127.17% | +852.47% | 57.34B | |
| +1.84% | -3.24% | -11.87% | +65.77% | 27.05B | |
| -0.93% | +0.91% | +26.09% | +88.13% | 25.68B | |
| -0.60% | +0.62% | +13.37% | +55.61% | 25.59B | |
| -0.69% | +3.27% | +40.48% | +393.46% | 21.64B | |
| +0.62% | -0.70% | -17.85% | -0.04% | 21.01B | |
| -2.67% | -0.29% | +12.03% | +94.79% | 20B | |
| +1.50% | +2.53% | +0.62% | +36.13% | 17.09B | |
| Average | -0.12% | +1.91% | +21.38% | +170.28% | 42.69B | |
| Weighted average by Cap. | -0.06% | +1.79% | +26.35% | +180.89% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 418B 373B 348B 316B 594B 39,682B 599B 4,170B 1,632B 20,637B 1,570B 1,536B 66,223B | 430B 384B 358B 325B 611B 40,822B 616B 4,290B 1,679B 21,230B 1,615B 1,580B 68,126B |
| Net income | 8.87B 7.93B 7.39B 6.7B 12.61B 842B 12.71B 88.52B 34.65B 438B 33.33B 32.6B 1,406B | 9.32B 8.32B 7.76B 7.03B 13.24B 885B 13.34B 92.95B 36.39B 460B 35B 34.23B 1,476B |
| Net Debt | 51.89B 46.35B 43.2B 39.17B 73.71B 4,925B 74.29B 518B 203B 2,562B 195B 191B 8,220B | 48.85B 43.63B 40.67B 36.87B 69.39B 4,637B 69.94B 487B 191B 2,411B 183B 179B 7,738B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-10-13 | US$87.55 | -0.22% | 10,479,087 |
| 26-10-12 | US$87.74 | +1.83% | 11,574,532 |
| 26-10-09 | US$86.16 | -1.87% | 11,652,362 |
| 26-10-08 | US$87.80 | -0.17% | 7,833,882 |
| 26-10-07 | US$87.95 | +1.76% | 8,468,977 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- CVS Stock
Select your edition
All financial news and data tailored to specific country editions
